263 related articles for article (PubMed ID: 16133112)
21. Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).
Miyake Y; Nishimura J; Kato T; Ikeda M; Tsujie M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M;
Surg Today; 2018 Jan; 48(1):66-72. PubMed ID: 28634730
[TBL] [Abstract][Full Text] [Related]
22. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.
Sakamoto J; Hamada C; Yoshida S; Kodaira S; Yasutomi M; Kato T; Oba K; Nakazato H; Saji S; Ohashi Y
Br J Cancer; 2007 Apr; 96(8):1170-7. PubMed ID: 17375049
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy of gastric cancer: the Japanese experience.
Fukushima M
Semin Oncol; 1996 Jun; 23(3):369-78. PubMed ID: 8658221
[TBL] [Abstract][Full Text] [Related]
24. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
25. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of Adjuvant Immunochemotherapy Using OK-432 in Patients With Resected Non-Small-Cell Lung Cancer.
Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y
J Immunother (1991); 2001 May; 24(3):250-256. PubMed ID: 11395641
[TBL] [Abstract][Full Text] [Related]
28. [Subset analysis of preoperative lymphocyte ratio in stage II or III colorectal cancer patients treated with oral tegafur-uracil and protein-bound polysaccharide K].
Totsuka O; Kawate S; Hirai K; Ogawa H; Toya H; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2525-8. PubMed ID: 24335363
[TBL] [Abstract][Full Text] [Related]
29. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer.
Torisu M; Hayashi Y; Ishimitsu T; Fujimura T; Iwasaki K; Katano M; Yamamoto H; Kimura Y; Takesue M; Kondo M
Cancer Immunol Immunother; 1990; 31(5):261-8. PubMed ID: 2198088
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer.
Yoshitani S; Takashima S
Cancer Biother Radiopharm; 2009 Feb; 24(1):35-40. PubMed ID: 19243246
[TBL] [Abstract][Full Text] [Related]
31. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis.
Oba K
Int J Clin Oncol; 2009 Apr; 14(2):85-9. PubMed ID: 19390937
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials.
Sakamoto J; Hamada C; Kodaira S; Nakazato H; Ohashi Y
Jpn J Clin Oncol; 1999 Feb; 29(2):78-86. PubMed ID: 10089948
[TBL] [Abstract][Full Text] [Related]
34. An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer.
Sakamoto J; Hamada C; Rahman M; Kodaira S; Ito K; Nakazato H; Ohashi Y; Yasutomi M
Jpn J Clin Oncol; 2005 Sep; 35(9):536-44. PubMed ID: 16155120
[TBL] [Abstract][Full Text] [Related]
35. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
36. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.
Oba K; Paoletti X; Alberts S; Bang YJ; Benedetti J; Bleiberg H; Catalano P; Lordick F; Michiels S; Morita S; Ohashi Y; Pignon JP; Rougier P; Sasako M; Sakamoto J; Sargent D; Shitara K; Cutsem EV; Buyse M; Burzykowski T;
J Natl Cancer Inst; 2013 Nov; 105(21):1600-7. PubMed ID: 24108812
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709
[TBL] [Abstract][Full Text] [Related]
38. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up.
Ito K; Nakazato H; Koike A; Takagi H; Saji S; Baba S; Mai M; Sakamoto J; Ohashi Y;
Int J Colorectal Dis; 2004 Mar; 19(2):157-64. PubMed ID: 13680286
[TBL] [Abstract][Full Text] [Related]
39. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer.
Iino Y; Yokoe T; Maemura M; Horiguchi J; Takei H; Ohwada S; Morishita Y
Anticancer Res; 1995; 15(6B):2907-11. PubMed ID: 8669887
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
